Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 22
1946 60
1947 64
1948 54
1949 38
1950 44
1951 91
1952 169
1953 116
1954 106
1955 97
1956 118
1957 121
1958 128
1959 88
1960 85
1961 84
1962 66
1963 81
1964 92
1965 126
1966 142
1967 139
1968 173
1969 189
1970 182
1971 200
1972 219
1973 251
1974 277
1975 262
1976 327
1977 309
1978 307
1979 324
1980 268
1981 345
1982 397
1983 357
1984 399
1985 357
1986 405
1987 405
1988 394
1989 374
1990 415
1991 352
1992 364
1993 420
1994 347
1995 467
1996 418
1997 408
1998 451
1999 472
2000 480
2001 564
2002 666
2003 753
2004 772
2005 973
2006 1235
2007 1341
2008 1442
2009 1654
2010 1860
2011 1957
2012 2109
2013 2099
2014 1949
2015 2151
2016 2390
2017 2512
2018 2629
2019 2693
2020 2735
2021 2559
2022 1467
Text availability
Article attribute
Article type
Publication date

Search Results

47,526 results
Results by year
Filters applied: . Clear all
Page 1
Drug-Induced Nephrotoxicity: Pathogenic Mechanisms, Biomarkers and Prevention Strategies.
Wu H, Huang J. Wu H, et al. Curr Drug Metab. 2018;19(7):559-567. doi: 10.2174/1389200218666171108154419. Curr Drug Metab. 2018. PMID: 29119923 Review.
BACKGROUND: Risk factors of drug-induced nephrotoxicity include drug overdose, drug-drug interactions and drug-related adverse effects. Since the usage of some nephrotoxic drugs is still unavoidable in the clinical se …
BACKGROUND: Risk factors of drug-induced nephrotoxicity include drug overdose, drug-drug interactions and …
Drug-induced ototoxicity: Mechanisms, Pharmacogenetics, and protective strategies.
Lanvers-Kaminsky C, Zehnhoff-Dinnesen AA, Parfitt R, Ciarimboli G. Lanvers-Kaminsky C, et al. Clin Pharmacol Ther. 2017 Apr;101(4):491-500. doi: 10.1002/cpt.603. Epub 2017 Feb 3. Clin Pharmacol Ther. 2017. PMID: 28002638 Review.
Drug ototoxicity limits the quality of life of patients after treatment, having serious consequences, especially for psychosocial development of children. ...Moreover, possible protective strategies and important methods for early detection of ototoxic effects are d
Drug ototoxicity limits the quality of life of patients after treatment, having serious consequences, especially for psychosocial dev
Hyponatremia-Inducing Drugs.
Liamis G, Megapanou E, Elisaf M, Milionis H. Liamis G, et al. Front Horm Res. 2019;52:167-177. doi: 10.1159/000493246. Epub 2019 Jan 15. Front Horm Res. 2019. PMID: 32097944 Review.
Therefore, in the diagnostic approach of patients with low serum [Na+] levels, meticulous history taking and recording of pharmacotherapy is warranted to identify potentially culprit medications. Taking into account the adverse outcomes associated with even mild hyponatrem …
Therefore, in the diagnostic approach of patients with low serum [Na+] levels, meticulous history taking and recording of pharmacotherapy is …
A Review and Assessment of Drug-Induced Thrombocytosis.
Vo QT, Thompson DF. Vo QT, et al. Ann Pharmacother. 2019 May;53(5):523-536. doi: 10.1177/1060028018819450. Epub 2018 Dec 10. Ann Pharmacother. 2019. PMID: 30525921 Review.
In all, 43 case reports of drug-induced thrombocytosis from a wide variety of drugs and drug classes were reviewed using a modified Naranjo probability scale that included criteria specific for thrombocytosis. CONCLUSIONS: Drug-induced thrombocy …
In all, 43 case reports of drug-induced thrombocytosis from a wide variety of drugs and drug classes were reviewed usin …
Adverse Drug Reactions: Type A (Intrinsic) or Type B (Idiosyncratic).
Iasella CJ, Johnson HJ, Dunn MA. Iasella CJ, et al. Clin Liver Dis. 2017 Feb;21(1):73-87. doi: 10.1016/j.cld.2016.08.005. Epub 2016 Oct 13. Clin Liver Dis. 2017. PMID: 27842776 Review.
Hepatotoxic adverse drug reactions are associated with significant morbidity and mortality and are the leading cause of postmarketing regulatory action in the United States. ...Type B are not clearly related to increasing dose and are associated with drug
Hepatotoxic adverse drug reactions are associated with significant morbidity and mortality and are the leading cause of postma …
Immune-related toxicities of checkpoint inhibitors: mechanisms and mitigation strategies.
Sullivan RJ, Weber JS. Sullivan RJ, et al. Nat Rev Drug Discov. 2022 Jul;21(7):495-508. doi: 10.1038/s41573-021-00259-5. Epub 2021 Jul 27. Nat Rev Drug Discov. 2022. PMID: 34316029 Review.
The immune-related adverse events associated with treatment with immune checkpoint inhibitors result in significant morbidity for patients as well as considerable cost to the health-care system, and can limit the use of these beneficial drugs. Understanding t …
The immune-related adverse events associated with treatment with immune checkpoint inhibitors result in significant mor …
Risks and management of antiepileptic drug induced skin reactions in the adult out-patient setting.
Fowler T, Bansal AS, Lozsádi D. Fowler T, et al. Seizure. 2019 Nov;72:61-70. doi: 10.1016/j.seizure.2019.07.003. Epub 2019 Jul 3. Seizure. 2019. PMID: 31708349 Free article. Review.
Adverse cutaneous reactions caused by mostly aromatic antiepileptic drugs (AED) affect 50.000 people a year in the United Kingdom (UK; incidence 75.7/100.000). ...Our study provides a summary of severe delayed allergic reactions and offers a pragmatic management pathway fo
Adverse cutaneous reactions caused by mostly aromatic antiepileptic drugs (AED) affect 50.000 people a year in the United Kingdom (UK
New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management.
Kroschinsky F, Stölzel F, von Bonin S, Beutel G, Kochanek M, Kiehl M, Schellongowski P; Intensive Care in Hematological and Oncological Patients (iCHOP) Collaborative Group. Kroschinsky F, et al. Crit Care. 2017 Apr 14;21(1):89. doi: 10.1186/s13054-017-1678-1. Crit Care. 2017. PMID: 28407743 Free PMC article. Review.
Pharmacological and cellular treatment of cancer is changing dramatically with benefits for patient outcome and comfort, but also with new toxicity profiles. The majority of adverse events can be classified as mild or moderate, but severe and life-threatening compli …
Pharmacological and cellular treatment of cancer is changing dramatically with benefits for patient outcome and comfort, but also with new t …
[Induced drug uveitis and drug side effects in ophthalmology].
Trad S, Bonnet C, Monnet D. Trad S, et al. Rev Med Interne. 2018 Sep;39(9):699-710. doi: 10.1016/j.revmed.2018.02.017. Epub 2018 Mar 9. Rev Med Interne. 2018. PMID: 29526327 Review. French.
Ocular drug side effects are very varied and can affect all the structures of the eye. The purpose of this review is to help clinicians: (i) to evoke this drug-induced toxicity yearly in the course of an unexplained ocular injury, before its dam …
Ocular drug side effects are very varied and can affect all the structures of the eye. The purpose of this review is to …
Immune-related adverse events with PD-1 versus PD-L1 inhibitors: a meta-analysis of 8730 patients from clinical trials.
Sonpavde GP, Grivas P, Lin Y, Hennessy D, Hunt JD. Sonpavde GP, et al. Future Oncol. 2021 Jul;17(19):2545-2558. doi: 10.2217/fon-2020-1222. Epub 2021 Mar 30. Future Oncol. 2021. PMID: 33783228 Free article.
Background: Trial-level meta-analysis to investigate differences in immune-related adverse event (irAE) profiles between anti-PD-1/PD-L1 antibodies. ...
Background: Trial-level meta-analysis to investigate differences in immune-related adverse event (irAE) profiles between anti- …
47,526 results
You have reached the last available page of results. Please see the User Guide for more information.